RED ONE Pharma SRL
RED ONE Pharma reported total assets of €1.19m at the end of the 2025 financial year (annual accounts filed with the NBB on 18 Jun 2026).
The score of RED ONE Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +7 % Total assets -3 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
RED ONE Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 18 Jun 2026
- Year ended 31 Dec 2024filed on 19 Jun 2025
- Year ended 31 Dec 2023filed on 01 Jul 2024
- Year ended 31 Dec 2022filed on 15 Jun 2023
- Year ended 31 Dec 2021filed on 16 Jun 2022
RED ONE Pharma's financial analysis
- Solvency43.2%sector median: 37.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of RED ONE Pharma
RED ONE Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0684.757.741
- VAT number
- BE0684757741
- Peppol
- Registered · 0208:0684757741 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Nov 2017
- Registered office
- 1020 Brussels
- Latest accounts
- 2025 · filed on 18 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
RED ONE Pharma (SRL) has been based in Brussels since 2017, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 108,754 € and equity of 513,675 €; its revenue is not published. Its solvency stands at 43.2%, above the median of its sector (37.6%).
Companies similar to RED ONE Pharma
Companies in the same business, of comparable size and area, outside its group.
- Ardal Pharma Business and other management consultancy activities Jette · balance sheet €1.22m
- Filepharma Invest Activities of head offices Soignies · balance sheet €1.10m
- Mathis Pharma Business and other management consultancy activities Bruges · balance sheet €1.06m
- T-Oline Business and other management consultancy activities Ferrières · balance sheet 987,312 €
- Crobephar Business and other management consultancy activities Quévy · balance sheet €1.56m
- Sodyss Retail sale of pharmaceutical products Diest · balance sheet €1.02m
- Famaro Retail sale of pharmaceutical products Tongeren-Borgloon · balance sheet €1.18m
- Juclé Retail sale of pharmaceutical products Sint-Truiden · balance sheet €1.06m
Frequently asked questions about RED ONE Pharma
What is the revenue of RED ONE Pharma?
RED ONE Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of RED ONE Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0684757741 for RED ONE Pharma, if the company is VAT-registered. Its company number (CBE) is 0684.757.741.
Where is the registered office of RED ONE Pharma?
According to the CBE register, the registered office of RED ONE Pharma is in 1020 Brussels.
What is the equity of RED ONE Pharma?
At the close of the 2025 financial year, the equity of RED ONE Pharma amounts to 513,675 €, a solvency of 43.2% of total assets.
Who manages RED ONE Pharma?
The register lists 1 active mandates at RED ONE Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of RED ONE Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →